搜索
1

1

News Center
/
Latest News
11-11

Make an Appointment with AIVD at MEDICA 2022

We are happy to announce that AIVD is going to exhibit at MEDICA 2022 from November 14th to 17th in Düsseldorf.
10-31

Innovation, Win-Win - AIVD CACLP 2022 Highlights Review

On October 26-28, 2022, the 19th China Association of Clinical Laboratory Practice Expo (CACLP) was successfully held in Nanchang, China, where more than 1400 in vitro diagnostic companies from the whole industry chain gathered to share this industry feast.
10-19

AIVD successfully developed a 25-OH-D assay with a clinical compound rate of >95%

25-OH-D plays an important physiological role in osteoporosis, rickets, chronic kidney disease (CKD) and skin diseases, especially in the regulation of calcium and phosphorus metabolism and maintenance of bone health, while its role in muscle, cardiovascular disease, diabetes, cancer, autoimmune and inflammatory responses is also gaining attention.
10-12

Monkeypox Testing Guideline 2022

What are the signs of a monkeypox virus infection, how is it spread, and how is it diagnosed?
09-08

The performance of the AIVD glycosylated hemoglobin paired antibody and chromatography uncut sheet is comparable to that of well-known international brands

According to the International Diabetes Federation, glycated hemoglobin (HbA1c) is the "gold standard" for monitoring diabetes and is crucial for both diagnosing and treating the condition. The glycated hemoglobin level has significant therapeutic relevance for assessing the overall control of blood sugar, identifying treatment-related issues, and directing treatment strategies in the management of diabetes.
04-14

The first in China | AIVD launched six diagnostic raw materials for self-developed new thrombosis

The pathological process of thrombotic diseases involves three major systems: vascular endothelium, coagulation and fibrinolysis. It has been confirmed that in the prethrombotic state, the vascular endothelium, coagulation and fibrinolysis systems have been changed. TAT, PIC, TM, t-PAIC, FDP and D-Dimer are effective responses to the early changes of the body's vascular endothelium, coagulation and fibrinolysis systems. effective indicator. It is suitable for early diagnosis and risk assessment of high-risk groups of thrombosis in various clinical departments.
03-21

Heavy upgrade丨AIVD Security Lab P2 certification passed!

Recently, AIVD Security Lab successfully passed BSL-2 (ie P2) level certification. The acquisition of the P2 laboratory qualification further proves that the company has the technology and ability to provide better services to customers.
Previous page
1

Shenzhen AIVD Biotechnology Co. , LTD.

A4 Building 4th Floor / B5 Building C501, China Merchants Bright Technology Park, Fenghuang Street, Guangming District, Shenzhen, Guangdong Province, China

E-mail:market@aivdbiotech.com 
             info@aivdbiotech.com

Tel:+86-755-26165742   +86 18543132823

WhatsApp:+86 18543132823

facebook facebook facebook facebook facebook

© 2022 Shenzhen AIVD Biotechnology Co.,LTD.     粤ICP备18093805号